These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24116392)
1. "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter. Kolanos R; Solis E; Sakloth F; De Felice LJ; Glennon RA ACS Chem Neurosci; 2013 Dec; 4(12):1524-9. PubMed ID: 24116392 [TBL] [Abstract][Full Text] [Related]
2. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765 [TBL] [Abstract][Full Text] [Related]
3. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter. Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489 [TBL] [Abstract][Full Text] [Related]
4. Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV. Steele TWE; Spires Z; Jones CB; Glennon RA; Dukat M; Eltit JM Neuropharmacology; 2021 Dec; 200():108820. PubMed ID: 34619165 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters. Solis E Curr Top Behav Neurosci; 2017; 32():73-92. PubMed ID: 27677783 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats. Kolanos R; Partilla JS; Baumann MH; Hutsell BA; Banks ML; Negus SS; Glennon RA ACS Chem Neurosci; 2015 May; 6(5):771-7. PubMed ID: 25688761 [TBL] [Abstract][Full Text] [Related]
8. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter. Shekar A; Aguilar JI; Galli G; Cozzi NV; Brandt SD; Ruoho AE; Baumann MH; Matthies HJG; Galli A J Chem Neuroanat; 2017 Oct; 83-84():69-74. PubMed ID: 28163218 [TBL] [Abstract][Full Text] [Related]
9. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561 [TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. Anneken JH; Angoa-Pérez M; Kuhn DM J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880 [TBL] [Abstract][Full Text] [Related]
11. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters. Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092 [TBL] [Abstract][Full Text] [Related]